Open access · US-GOV
via ClinicalTrials.gov Clinical trial
The Clinical Utility of ERPs in the Diagnosis of Cognitive Impairment
Authors not listed
Boston University · 2023
Abstract
In this study, the investigators will use a novel electroencephalogram (EEG) system that participants will wear during a single in-person research session to investigate whether ERPs are now ready for validation as a tool clinicians can easily implement to increase diagnostic accuracy and confidence. This EEG will not be used to treat, cure, mitigate or diagnosis any disease and there will be no safety or efficacy data collected about the machine for any purpose including support of FDA submission.
The investigators will compare the ERP data to that of neuropsychological testing in order to determine the degree of correlation between these two measures. Questionnaires on cognition, mood, and fluency will be administered prior to the EEG to establish a baseline. ERP data from the EEG session will be compared with the results of the neuropsychological battery in order to determine whether the implementation of ERPs in the existing workflow of clinicians can aid in diagnostic accuracy, thus altering clinical management.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-07 MST
Cite this
APA
Anonymous. (2023). The Clinical Utility of ERPs in the Diagnosis of Cognitive Impairment. <em>Boston University</em>. https://clinicaltrials.gov/study/NCT05673759
Vancouver
Anonymous. The Clinical Utility of ERPs in the Diagnosis of Cognitive Impairment. Boston University. 2023.
BibTeX
@misc{anon2023TheCli,
title = {The Clinical Utility of ERPs in the Diagnosis of Cognitive Impairment},
author = {Anonymous},
journal = {Boston University},
year = {2023},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
biorxiv 2025
Preprint · CC-BY
Building Multivariate Molecular Imaging Brain Atlases Using the NeuroMark PET Independent Component Analysis Framework
Bright Cloud International Corp 2021
Open access · US-GOV
Telerehabilitation Combining Virtual Reality Adaptable Games and Drug Therapy for Early Alzheimer's Disease - Usability
Clinika de Kay SL 2022
Open access · US-GOV
Smart and Healthy Ageing Through People Engaging in Supportive Systems (SHAPES) Digital App and Platform for Supporting Medicines Control and Optimization in Older Individuals With Heart Failure
NYU Langone Health 2021
Open access · US-GOV
Transcranial Photobiomodulation for Alzheimer's Disease (TRAP-AD)
Manuka Health 2023
Open access · US-GOV
An Investigation of the Effects of a Royal Jelly and Bee Venom-Derived Skin Serum on Skin Health and Signs of Aging
ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) 2024
Preprint · CC-BY